• Research Highlights

Programme 4

AI and Pharmaceuticals in Non-Communicable Diseases (NCDs)

Improved medication effectiveness in real-life settings and enhanced medication safety surveillance are the aim of this programme, which will draw on the database of Hong Kong’s Hospital Authority to conduct a series of inter-linked and AI-driven projects on pharmaceuticals in Non-Communicable Diseases (NCDs).

This programme will attract collaborative research from the pharmaceutical industry, develop new prediction and decision-assistant tools for improved clinical management, and inform health policy planning in the Greater Bay Area.

Scientific Leadership

  • Professor Ian Wong

    Lead Scientist

  • Professor Esther Chan

    Co-Principal Investigator
    Professor, Department of Pharmacology and Pharmacy, The University of Hong Kong

  • Professor C.L. Cheung

    Co-Principal Investigator
    Associate Professor, Department of Pharmacology and Pharmacy, The University of Hong Kong

  • Professor Celine Chui

    Co-Principal Investigator
    Assistant Professor, School of Nursing, The University of Hong Kong

  • Professor Geraint Rees

    Co-Principal Investigator
    Dean and Professor of Cognitive Neurology, Faculty of Life Sciences, University College London

  • Professor Ian Douglas

    Co-Principal Investigator
    Professor of Pharmacoepidemiology, London School of Hygiene and Tropical Medicine

  • Professor Li Wei

    Co-Principal Investigator
    Professor of Pharmacoepidemiology and Drug Safety Research, University College London

  • Professor Mark Jit

    Co-Investigator
    Professor of Vaccine Epidemiology, London School of Hygiene and Tropical Medicine
    Visiting Professor, School of Public Health, The University of Hong Kong

  • Dr Angel Wong

    Co-Principal Investigator
    Assistant Professor, Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine

  • Dr Carlos Wong

    Co-Principal Investigator

  • Professor Eric Wan

    Co-Principal Investigator
    Assistant Professor, Department of Pharmacology and Pharmacy, The University of Hong Kong

  • Professor Francisco Lai

    Co-Principal Investigator
    Assistant Professor, Department of Pharmacology and Pharmacy, The University of Hong Kong

  • Professor Shirley Li

    Co-Principal Investigator
    Assistant Professor, Department of Pharmacology and Pharmacy, The University of Hong Kong

  • Dr Wallis Lau

    Co-Principal Investigator
    Lecturer, School of Pharmacy, University College London

Projects

Burden of pneumococcal disease in children and adults in Hong Kong

The primary objective of this project is to estimate the annual hospitalized incidences, time trends and case-fatality rates associated with invasive pneumococcal disease (IPD), pneumonia and otitis media (OM) episodes, as well as to assess healthcare resource utilization (HCRU) and costs associated with each pneumococcal disease episode from 2005 to 2019. The project will provide a comprehensive and up-to-date assessment of the residual and vaccine-preventable burden of pneumococcal disease in Hong Kong by covering all major pneumococcal disease manifestations. This could help understand the impact of pneumococcal vaccination and inform future health policy planning.

Featured Publications

More programmes